These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 16953388

  • 41. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A, Martinez AA, Giuffrida A.
    Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
    [Abstract] [Full Text] [Related]

  • 42. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R, Molleman A, Parsons ME.
    Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
    [Abstract] [Full Text] [Related]

  • 43. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M, Scherma M, Tanda G, Wertheim CE, Fratta W, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [Abstract] [Full Text] [Related]

  • 44. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V, Kastellakis A, Panagis G.
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [Abstract] [Full Text] [Related]

  • 45. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 46. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
    Wakley AA, Rasmussen EB.
    Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
    [Abstract] [Full Text] [Related]

  • 47. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M, Fernández-Suárez D, Rojo-Bustamante E, Echeverry-Alzate V, Ramírez MJ, Hillard CJ, López-Moreno JA, Maldonado R, Oyarzábal J, Franco R, Aymerich MS.
    Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
    [Abstract] [Full Text] [Related]

  • 48. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
    Ruginsk SG, Uchoa ET, Elias LL, Antunes-Rodrigues J.
    Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
    [Abstract] [Full Text] [Related]

  • 49. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway.
    McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB.
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):664-71. PubMed ID: 22325231
    [Abstract] [Full Text] [Related]

  • 50. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 51. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
    Umathe SN, Manna SS, Jain NS.
    Behav Brain Res; 2011 Sep 30; 223(1):125-34. PubMed ID: 21549765
    [Abstract] [Full Text] [Related]

  • 52. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.
    Vlachou S, Nomikos GG, Stephens DN, Panagis G.
    Behav Pharmacol; 2007 Jul 30; 18(4):311-9. PubMed ID: 17551324
    [Abstract] [Full Text] [Related]

  • 53. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.
    Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20270-5. PubMed ID: 19918051
    [Abstract] [Full Text] [Related]

  • 54. Endocannabinoid signaling mediates oxytocin-driven social reward.
    Wei D, Lee D, Cox CD, Karsten CA, Peñagarikano O, Geschwind DH, Gall CM, Piomelli D.
    Proc Natl Acad Sci U S A; 2015 Nov 10; 112(45):14084-9. PubMed ID: 26504214
    [Abstract] [Full Text] [Related]

  • 55. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct 10; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 56. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
    Rubino T, Realini N, Castiglioni C, Guidali C, Viganó D, Marras E, Petrosino S, Perletti G, Maccarrone M, Di Marzo V, Parolaro D.
    Cereb Cortex; 2008 Jun 10; 18(6):1292-301. PubMed ID: 17921459
    [Abstract] [Full Text] [Related]

  • 57. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
    Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ.
    Neuropharmacology; 2017 Oct 10; 125():220-230. PubMed ID: 28754373
    [Abstract] [Full Text] [Related]

  • 58. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV, Casarotto PC, Resstel LB, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):434-8. PubMed ID: 21111767
    [Abstract] [Full Text] [Related]

  • 59. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.
    Adamczyk P, McCreary AC, Przegalinski E, Mierzejewski P, Bienkowski P, Filip M.
    J Physiol Pharmacol; 2009 Sep 30; 60(3):119-25. PubMed ID: 19826190
    [Abstract] [Full Text] [Related]

  • 60. Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB(1) receptors.
    Ferreira-Junior NC, Fedoce AG, Alves FH, Corrêa FM, Resstel LB.
    Am J Physiol Regul Integr Comp Physiol; 2012 Apr 30; 302(7):R876-85. PubMed ID: 22204950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.